MX2009001925A - Composicion farmaceutica oral para uso en enfermedades respiratorias. - Google Patents
Composicion farmaceutica oral para uso en enfermedades respiratorias.Info
- Publication number
- MX2009001925A MX2009001925A MX2009001925A MX2009001925A MX2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A MX 2009001925 A MX2009001925 A MX 2009001925A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- oral pharmaceutical
- respiratory diseases
- composition
- relates
- Prior art date
Links
- 239000008203 oral pharmaceutical composition Substances 0.000 title abstract 2
- 208000023504 respiratory system disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 abstract 1
- 229960003088 loratadine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000004005 microsphere Substances 0.000 abstract 1
- 239000000133 nasal decongestant Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 abstract 1
- 229960001802 phenylephrine Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica oral de liberación modificada en cápsulas con microesferas, que contiene loratadina, fenilefrina y vehículos o excipientes farmacéuticamente aceptables; dicha composición presenta una biodisponibilidad inmediata, con valores de concentración plasmática dentro de la ventana terapéutica con una liberación uniforme y continua; se refiere también a un proceso de fabricación de la composición y al uso de dicha composición indicada para el tratamiento como antihistamínico y descongestionante nasal.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009001925A MX2009001925A (es) | 2009-02-20 | 2009-02-20 | Composicion farmaceutica oral para uso en enfermedades respiratorias. |
US13/202,743 US20120064155A1 (en) | 2009-02-20 | 2009-10-01 | Oral pharmaceutical composition for use in respiratory diseases |
PCT/IB2009/007023 WO2010094996A1 (es) | 2009-02-20 | 2009-10-01 | Composición farmacéutica oral para uso en enfermedades respiratorias |
PE2011001495A PE20120173A1 (es) | 2009-02-20 | 2009-10-01 | Composicion farmaceutica oral que contiene loratadina y fenilefrina |
ARP100100462A AR075058A1 (es) | 2009-02-20 | 2010-02-17 | Composicion farmaceutica oral para uso en enfermedades respiratorias y proceso de fabricacion |
CR20110436A CR20110436A (es) | 2009-02-20 | 2011-08-16 | Composición farmacéutica oral para uso en enfermedades respiratorias |
DO2011000267A DOP2011000267A (es) | 2009-02-20 | 2011-08-19 | Composicion farmaceutica oral para uso en enfermedades respiratorias |
CO11105852A CO6410284A2 (es) | 2009-02-20 | 2011-08-19 | Composición farmacéutica oral para uso en enfermedades respiratorias |
HN2011002258A HN2011002258A (es) | 2009-02-20 | 2011-08-19 | Composicion farmacéutica oral para uso en enfermedades respiratorias nuevo titulo tecnico: composición farmacéutica oral que contiene loratadina y fenilefrina. ( a petición de la oficina) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2009001925A MX2009001925A (es) | 2009-02-20 | 2009-02-20 | Composicion farmaceutica oral para uso en enfermedades respiratorias. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009001925A true MX2009001925A (es) | 2010-08-20 |
Family
ID=42633450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009001925A MX2009001925A (es) | 2009-02-20 | 2009-02-20 | Composicion farmaceutica oral para uso en enfermedades respiratorias. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20120064155A1 (es) |
AR (1) | AR075058A1 (es) |
CO (1) | CO6410284A2 (es) |
CR (1) | CR20110436A (es) |
DO (1) | DOP2011000267A (es) |
HN (1) | HN2011002258A (es) |
MX (1) | MX2009001925A (es) |
PE (1) | PE20120173A1 (es) |
WO (1) | WO2010094996A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112017005574A2 (pt) | 2014-09-19 | 2017-12-12 | Procter & Gamble | formas de dosagem de liberação pulsada de fenilefrina |
MX2017001192A (es) * | 2017-01-26 | 2018-07-25 | Laboratorios Liomont S A De C V | Composicion farmaceutica de loratadina, fenilefrina, paracetamol y amantadina para su administracion oral, para el tratamiento de alopatias relacionadas a un resfriado comun. |
US10278930B2 (en) | 2017-03-16 | 2019-05-07 | The Procter & Gamble Company | Method for relieving sinus congestion |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1255968B (it) * | 1992-11-27 | 1995-11-17 | Composizioni farmaceutiche contenenti acido ursodesossicolico | |
US20050152967A1 (en) * | 2003-03-28 | 2005-07-14 | Pfab, Lp | Dynamic variable release |
JP5175278B2 (ja) * | 2006-06-01 | 2013-04-03 | エムエスディー コンシューマー ケア, インコーポレイテッド | 結腸吸収のためのフェニレフリン薬学的製剤および組成物 |
NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
RU2008151945A (ru) * | 2006-06-01 | 2010-07-20 | Шеринг Корпорейшн (US) | Лекарственные формы с пульсирующим высвобождением и фармацевтические композиции фенилэфрина |
-
2009
- 2009-02-20 MX MX2009001925A patent/MX2009001925A/es active IP Right Grant
- 2009-10-01 US US13/202,743 patent/US20120064155A1/en not_active Abandoned
- 2009-10-01 PE PE2011001495A patent/PE20120173A1/es active IP Right Grant
- 2009-10-01 WO PCT/IB2009/007023 patent/WO2010094996A1/es active Application Filing
-
2010
- 2010-02-17 AR ARP100100462A patent/AR075058A1/es not_active Application Discontinuation
-
2011
- 2011-08-16 CR CR20110436A patent/CR20110436A/es unknown
- 2011-08-19 CO CO11105852A patent/CO6410284A2/es not_active Application Discontinuation
- 2011-08-19 HN HN2011002258A patent/HN2011002258A/es unknown
- 2011-08-19 DO DO2011000267A patent/DOP2011000267A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR075058A1 (es) | 2011-03-09 |
DOP2011000267A (es) | 2011-12-31 |
HN2011002258A (es) | 2014-06-16 |
CO6410284A2 (es) | 2012-03-30 |
US20120064155A1 (en) | 2012-03-15 |
PE20120173A1 (es) | 2012-03-24 |
CR20110436A (es) | 2011-10-24 |
WO2010094996A1 (es) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
MX2011013902A (es) | Tratamiento de esclerosis multiple con laquinimod. | |
HK1104471A1 (en) | Opioids for the treatment of the chronic obstructive pulmonary disease (copd) | |
WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
PH12015500407B1 (en) | Methods of treating hypertriglyceridemia | |
MX2010005631A (es) | Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades. | |
MY146650A (en) | Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic | |
MX2009002196A (es) | Oblea de buprenorfina para terapia de sustitucion de farmacos. | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
PH12014502447A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
WO2012007159A3 (en) | Novel gastro-retentive dosage forms | |
WO2014064410A3 (en) | Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane | |
UA98136C2 (ru) | Применение аклидиния для лечения респираторных заболеваний | |
MY156302A (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES | |
ATE302774T1 (de) | Arzneimittel enthaltend betamimetika und ein neues anticholinergikum | |
RS54244B1 (en) | NALBUFINE BASED FORMULATIONS AND THEIR USE | |
AR091351A1 (es) | Formulaciones de bromocriptina, metodo para mejorar el control glucemico y metodo para la fabricacion | |
MX2009001925A (es) | Composicion farmaceutica oral para uso en enfermedades respiratorias. | |
RS89904A (en) | Medicaments containing steroids and a novel anticholinesterase drug | |
NZ597957A (en) | Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients | |
MX2010006317A (es) | Composicion farmaceutica oral con antihistaminico y descongestionante. | |
ECSP11011279A (es) | Composición farmacéutica oral para uso en enfermedades respiratorias | |
MX2011005899A (es) | Composicion farmacéutica con antihistamínico no sedante y combinaciones. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |